期刊文献+

抗肿瘤坏死因子相关凋亡诱导配体细胞外段单克隆抗体的制备 被引量:1

Preparation of Monoclonal Antibody against Extracellular Domain of TNF-related Apoptosis-induced Ligand
原文传递
导出
摘要 目的制备抗肿瘤坏死因子相关凋亡诱导配体细胞外段(sTRAIL)的单克隆抗体。方法用重组sTRAIL免疫BALB/c小鼠,取脾细胞与SP2/0细胞融合,捕获ELISA筛选阳性克隆,制备腹水抗体。间接ELISA测定单抗效价,并进行单抗亚类、特异性鉴定及杂交瘤细胞染色体和单抗识别位点分析。将杂交瘤细胞体外连续培养3个月及冻存6个月后,检测细胞培养上清的效价。结果3株杂交瘤细胞分泌的单抗均为IgG1型,腹水单抗效价均高于10-6,杂交瘤细胞染色体数介于94~98条之间,均识别sTRAIL分子上线性表位。细胞体外连续培养3个月及冻存6个月后的上清效价保持稳定。结论已成功制备了3株可稳定分泌抗sTRAIL单克隆抗体的杂交瘤细胞,为TRAIL的定性定量检测及组织表达分析奠定了基础。 Objective To prepare the monoclonal antibody(McAb)against amino acids 114-281 at extracellular domain of TNF-related apoptosis-induced ligand (TRAIL), i.e. sTRAIL. Methods BALB / c mice were immunized with recombinant sTRAIL, and their splenic cells were fused with SP2 / 0 cells, and positive clones were screened by capture ELISA to prepare McAb in ascites. The prepared McAb was determined for titer by indirect ELISA and analyzed for subclass and specificity. Meanwhile, the chromosome of hybridoma cells and recognition site of McAb were analyzed. The culture supernatants of hybridoma cells 3 months after culture in vitro and 6 months after storage in frozen were determined for McAb titers respectively. Results All the McAbs secreted by 3 hybridoma cell strains were IgG1, and their titers in ascites were higher than 10-6. The number of chromosome in hybridoma cells was 94~98. All the McAbs recognized the linear epitopes on sTRAIL molecules. The McAb titers in culture supernatants of hybridoma cells showed no significant change after culture in vitro for 3 months or storage in frozen for 6 months. Conclusion Three hybridoma cells stably secreting McAbs against sTRAIL were successfully established, and McAbs were prepared, which laid a foundation of qualitative and quantitative assays as well as expression of TRAIL.
出处 《中国生物制品学杂志》 CAS CSCD 2009年第12期1213-1215,共3页 Chinese Journal of Biologicals
关键词 肿瘤坏死因子相关凋亡诱导配体 胞外区 单克隆抗体 捕获ELISA TNF-related apoptosis-induced ligand(TRAIL) Extracellular domain Monoclonal Antibody Capture ELISA
  • 相关文献

参考文献7

  • 1Wiley SR, Schooley K, Smolak PJ, et al. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity, 1995, 3(6): 673-682.
  • 2Vannucchi S,Chiantore MV,Fiorucci G, et al.TRAIL is a key target in S-phase slowing-dependent apoptosis induced by interferonbeta in cervical carcinoma cells. Oncogene, 2005,24(15): 2536- 2546.
  • 3Chang MX, Nie P, Xie HX, et al. Characterization and expression analysis of TNF-related apoptosis inducing ligand (TRAIL) in grass carp etenopharyngodon idella. Vet Immunol Immunopathol, 2006, 110 (1-2): 51-63.
  • 4田生和,全家妩.人TRAIL细胞外段基因在大肠杆菌中的表达及其包涵体的复性[J].中国生物制品学杂志,2005,18(2):114-116. 被引量:3
  • 5田生和 杨京生 颜华 等.人可溶性TRAIL在包含体复性过程中快速纯化[J].中华医药杂志,2005,5(7):654-655.
  • 6哈洛E 莱恩D 著 沈关心 龚非力 丁洪波 译.抗体技术实验指南[M].北京:科学出版社,2002.44-45,4148-150,245-249.
  • 7MacFarlane M. TRAIL-induced signalling and apoptosis. Toxicol Lett, 2003, 139 (2-3): 89-97.

二级参考文献12

  • 1Wiley SR, Schooley K, Smolak PJ, et al. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity, 1995,3:673-682.
  • 2Guia T. How TRAIL kills cancer cells, but not normal cells. Science,1997,277:768.
  • 3French LE, Tschopp J. The TRAIL to selective tumor death. Nat Med, 1999,5:146-147.
  • 4Ashkenazi A, Pai RC, Fong S, et al. Safety and antitumor activity of recombinant soluble Apo2 ligand. J Clin Invest, 1999,104:155-162.
  • 5Smyth MJ, Takeda K, Hayakawa Y,et al. Nature's TRAIL on a path to cancer immunotherapy. Immunity, 2003,18:1-6.
  • 6MacFarlane M. TRAIL-induced signalling and apoptosis. Toxicol Lett,2003,139:89-97.
  • 7Hymowitz SG, O'Connell MP, Ultsch MH, et al.A unique zinc-binding site revealed by a high-resolution X-ray structure of homotrimeric Apo2I/TRAIL. Biochemistry, 2000,39: 633-640.
  • 8Ashkenazi A, Dixit VM. Apoptosis control by death and decoy receptors. Curr Opin Cell Bio1,1999,11:255-260.
  • 9Almasan A, Ashkenazi A. Apo2L/TRAIL: apoptosis signaling, biology,and potential for cancer therapy. Cytokine Growth Factor Rev,2003,14: 337-348.
  • 10Griffith TS, Lynch DH. TRAIL: a molecule with multiple receptors and control mechanisms. Curr Opin Immunol, 1998,10:559-563.

共引文献6

同被引文献8

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部